US FDA Advisory Panel Backs Takeda Ulcerative Colitis Drug

Takeda Pharmaceutical said on December 10 that the US FDA’s advisory panel of experts voted to recommend approval of Takeda’s vedolizumab, a drug to treat ulcerative colitis (UC) and Crohn’s disease (CD). Members of a joint panel of the FDA’s...read more